STARTER DOSE 3 mg STRENGTH 3 mg d NDC NUMBER 0169-4303-30 BOTTLE QUANTITY 30 x 3 mg per bottle THERAPEUTIC DOSE 7 mg STRENGTH 7 mg NDC NUMBER 0169-4307-30 BOTTLE QUANTITY 30 x 7 mg per bottle THERAPEUTIC DOSE 14 mg STRENGTH 14 mg NDC NUMBER 0169-4314-30 BOTTLE QUANTITY 30 x 14 mg per bottle d The 3 mg dose is intended for treatment initiation and is not effective for glycemic control
At Relive Health centers nationwide, we do not currently prescribe retatrutide due to its investigational status, lack of FDA approval, and the absence of legal prescribing and pharmacy dispensing pathways
Some donors have successfully donated while on stable GLP-1 therapy by providing this documentation upfront, though approval is never guaranteed and remains at the discretion of the plasma center's physician
Additionally, glycine supports the bodys natural detoxification processes and aids in muscle recovery and cellular repair
Do not use in pregnant or breastfeeding women, or those with a known allergy to Gluta-1s active ingredient
If a licensed doctor chooses to administer such a substance, this constitutes off-label use meaning the substance is used outside the scope of any approved indication